🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Suicidal Behavior in Patients Diagnosed With Bipolar Disorder

RecruitingNAAges 18 Years - 64 YearsAllEmory University
NCT02604277 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to learn the environmental and psychological factors that impact suicidality in patients diagnosed with Bipolar Disorder. Additionally, the study aims to identify treatments to reduce the suicidal behavior and improve quality of life through a 6-week group-based intervention program.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * English speaking * Diagnosis of Bipolar Disorder (BD) * Able to provide written informed consent Exclusion Criteria: * Cognitive impairments * Acutely psychotic * Medically unstable * History of schizophrenia spectrum disorder * History of mood incongruent psychotic symptoms * History of primary substance disorder * History of primary organic disease and/or dementia
💊

What it tests

  • Interpersonal and Social Rhythm Therapy (ISRT)
  • Bipolar-Specific Cognitive Behavioral Therapy (CBT)
  • Mindfulness-Based Stress Reduction (MBSR)
  • Psycho-education & Understanding Bipolar Medications Therapy
📍

Where

1 site
Grady Health System
Atlanta, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy